Oertle S, Mauron H, Villiger P. Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly [Internet]. 2002 Jul. 27 [cited 2024 Apr. 20];132(2930):414-. Available from: https://smw.ch/index.php/smw/article/view/197